Treace Medical Concepts Inc(TMCI) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 30 at 4:00 PM ET (Korea 10/31 05:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.93 | Insider Own | 26.71% | Shs Outstand | 65.2M | Perf Week | 3.75% |
| Market Cap | 0.29B | Forward P/E | - | EPS next Y | 8.94% | Insider Trans | 2.52% | Shs Float | 47.7M | Perf Month | 2.31% |
| Enterprise Value | 0.32B | PEG | - | EPS next Q | -0.25 | Inst Own | 49.01% | Short Float | 4.04% | Perf Quarter | -5.34% |
| Income | -0.06B | P/S | 1.4 | EPS this Y | 8.6% | Inst Trans | -9.68% | Short Ratio | 6.77 | Perf Half Y | 138.17% |
| Sales | 0.21B | P/B | 4.27 | EPS next 5Y | 9.18% | ROA | -30.72% | Short Interest | 1.92M | Perf YTD | 80.82% |
| Book/sh | 1.04 | P/C | 6.32 | EPS past 3/5Y | -6.38% -61.76% | ROE | -71.99% | 52W High | -33.38% ($6.65) | Perf Year | -30.24% |
| Cash/sh | 0.7 | P/FCF | - | Sales past 3/5Y | 14.46% 29.96% | ROIC | -43.48% | 52W Low | 278.63% ($1.17) | Perf 3Y | -54.21% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -17.9% | Gross Margin | 79.45% | Volatility(W/M) | 8.68% 6.47% | Perf 5Y | -80.79% |
| Dividend TTM | - | EV/Sales | 1.54 | Sales Y/Y TTM | -3.95% | Oper. Margin | -26.17% | ATR (14) | 0.28 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.95 | EPS Q/Q | 11.63% | Profit Margin | -28.99% | RSI (14) | 51.61 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.9 | Sales Q/Q | -4.24% | SMA20 | 5.03% ($4.22) | Beta | 1.6 | Target Price | $5.5 |
| Payout | - | Debt/Eq | 1.08 | Earnings | 2026/11/6 | SMA50 | 0.12% ($4.42) | Rel Volume | 1.02 | Prev Close | $5.06 |
| Employees | 450 | LT Debt/Eq | 1.02 | EPS/Sales Surpr. | 19.46% 3.08% | SMA200 | 36.91% ($3.24) | Avg Volume(3M) | 0.28M | Price | $4.43 |
| IPO | 2021/4/23 | Option/Short | Yes/Yes | Trades | 2887 | Volume | 290,599 | Change | -12.45% |
A US medical device company that develops and supplies surgical devices for foot and ankle correction, including those used for hallux valgus (bunions) and other related procedures. The company has grown in the foot and ankle orthopedic market by centering its operations around its flagship product, the Lapiplasty 3D Bunion Correction System, while also providing surgeon education and surgical solutions.
Over the past 1 year, roughly in the middle
33% below its 1-year high.
Traded about as much as usual. That is 102% of its average volume.
Next earnings report: November 6
6 days to go.
TMCI has a sound balance sheet but weak earning power
Of every $100 in sales, $26.17 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +8.6% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $140. Peers typically go for $143.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -80.8%. The S&P 500 did +65% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership looks stable
Institutions hold 49.0%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #71 of 142 in the industry
Based on market cap of $288M.
CLPT#69 ClearPoint Neuro Inc $342M PER - 
QSI#70 Quantum-Si Incorporated $320M PER - TMCI#71 Treace Medical Concepts Inc $288M PER - 
INFU#72 InfuSystem Holdings Inc $280M PER 34.5 
LAB#73 Standard BioTools Inc $241M PER - 
FAQ
What kind of company is TMCI?
TMCI belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of TMCI?
The market cap of TMCI is approximately $288M, ranking 3,680 within its sector.
What is the 52-week high and low for TMCI?
TMCI has recorded a 52-week high of $6.65 and a low of $1.17.
